Clinical Trial: The Gut Microbiome and Immunotherapy Response in Solid Cancers
Study Status: Completed
Recruit Status: RECRUITING
Condition: Cancer
Study Type: OBSERVATIONAL
Official Title: The Gut Microbiome and Immunotherapy Response in Solid Cancers
Brief Summary:
The aim of this study is characterize the gastrointestinal microbiomes of patient with solid cancer undergoing standard of care treatment with programmed cell death protein 1 (PD-1) /programmed cell death ligand (PD-L1) blockade.
Read more